• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Cerner Announces Appointment of David Feinberg, M.D. as President and Chief Executive Officer

    8/19/21 4:30:00 PM ET
    $CERN
    Managed Health Care
    Health Care
    Get the next $CERN alert in real time by email

    Highly Accomplished Visionary with Proven Track Record of Leading Healthcare Businesses

    Cerner Board Separates Chairman and CEO Roles and Names William Zollars Chairman of Board of Directors

    KANSAS CITY, Mo., Aug. 19, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (NASDAQ:CERN) today announced that its Board of Directors has appointed David Feinberg, M.D., MBA, as President and Chief Executive Officer, effective October 1, 2021. He succeeds Brent Shafer, who previously announced his decision to transition from chairman and CEO. Dr. Feinberg will serve as a member of the Board of Directors. Cerner's current President, Donald Trigg, will leave Cerner. Cerner's Board of Directors also announced that it will separate the roles of chairman and Chief Executive Officer and has appointed William Zollars as independent chairman, also effective October 1, 2021.

    Dr. Feinberg, 59, has served in numerous senior leadership roles during his more than 25-year career in healthcare, and joins Cerner from Google. Since 2019, Dr. Feinberg was the Vice President of Google Health, where he led Google's worldwide health efforts, bringing together groups from across Google and Alphabet that used artificial intelligence, product expertise and hardware to tackle some of healthcare's biggest challenges, and was responsible for organizing and innovating Google's various healthcare initiatives. Prior to Google, he served as President and CEO of Geisinger Health—a physician-led health system, and one of the nation's most innovative health services organizations. At Geisinger, Dr. Feinberg led an operational turnaround, and pushed the use of new platforms and tools, including an IT system called a Unified Data Architecture that allowed the company to integrate big data into existing data analytics and management systems. During his Geisinger tenure, Dr. Feinberg also introduced programs and services to put a greater focus on precision medicine and better patient care. Prior to Geisinger, Dr. Feinberg worked at UCLA for more than 20 years and served in a number of leadership roles, including President, CEO and Associate Vice Chancellor of UCLA Health Sciences, Vice Chancellor and CEO for the UCLA Hospital System, and CEO of UCLA's Ronald Reagan Medical Center. Throughout his career, Dr. Feinberg has been driven by a passion to leverage technology to better-enable providers to deliver the very best clinical care.

    "Over the past few months, our Board conducted an extensive search for a CEO candidate with the expertise and ability to effectively capitalize on the opportunities in the market we serve," said Mitch Daniels, member of the Cerner Board and Chair of the Nominating, Governance and Public Policy Committee. "With his exceptional track record of leading and innovating programs to improve patient care, technology experience, and industry expertise, we believe Dr. Feinberg is the ideal CEO to lead Cerner in its next chapter of growth and success."

    "On behalf of the entire Cerner Board and organization, I want to thank Brent for his dedicated service and commitment to transforming Cerner over the last three-plus years and express our appreciation that he will ensure a smooth transition," said William Zollars, lead independent director and incoming chairman of the Board. "We are fortunate to have someone with Dr. Feinberg's skills, vision and operational expertise to lead Cerner at such a pivotal time in our evolution. We are thrilled to welcome him to the Cerner family and look forward to benefiting from his insights and leadership as we continue evolving and executing our strategies."

    "I am honored to join Cerner and look forward to working closely with Cerner's talented associates as we continue to profitably grow the business by driving global healthcare transformation," Dr. Feinberg said. "Throughout my career, I've been guided by the goal of improving patient health and reducing the complexity of the healthcare system. I am thrilled to join a company that is so uniquely well-positioned to provide technology solutions that enable clinicians to take better care of patients while driving better clinical, operational, and financial outcomes for organizations of all sizes. I look forward to expanding opportunities for Cerner clients and associates while affecting real change in healthcare and enhancing value for our shareholders."

    "Cerner will be well-served under Dr. Feinberg's capable leadership," Mr. Shafer said. "Dr. Feinberg has had an exceptional career in healthcare, and his industry expertise, patient-centric mindset, and organizational leadership experience make him ideally qualified to lead the company through its next chapter. I am delighted to work closely with Dr. Feinberg as we begin the transition."

    Mr. Zollars said, "I would like to thank Don for his impact at Cerner. He has helped shape the trajectory of the company and our role within the industry. We wish him the best in his future endeavors."

    About David Feinberg, M.D.

    In his most recent role, Dr. Feinberg served as Vice President of Google Health. Prior to that role Dr. Feinberg was President & CEO of Geisinger, one of the nation's most innovative health services organizations. While at Geisinger, David oversaw 13 hospital campuses, a 600,000-member health plan, research centers, and various initiatives aimed at better engaging patients around their health and well-being. Prior to Geisinger, Dr. Feinberg served as CEO of UCLA's hospitals and associate vice chancellor of UCLA Health Sciences, as well as president of UCLA Health System. Dr. Feinberg earned his undergraduate degree at the University of California, Berkeley. He graduated with distinction from the University of Health Sciences/Chicago Medical School. He completed an internship in pediatrics at Loyola University Medical Center, and residency and fellowship training in psychiatry, addiction psychiatry, and child and adolescent psychiatry at the UCLA School of Medicine. He earned a Master of Business Administration from Pepperdine University. A well-known national speaker and author of numerous articles and co-author of "ProvenCare," Dr. Feinberg is a member of the Alpha Omega Alpha Medical Honor Society, a Distinguished Fellow of American Psychiatric Association and received the Cancro Academic Leadership Award from the American Academy of Child & Adolescent Psychiatry.

    About William Zollars

    Mr. Zollars has been a member of the Cerner Board of Directors since May 2005 and has served as lead independent director since April 2019. Mr. Zollars is the former chairman, president and chief executive officer of YRC Worldwide (now known as YRC Freight). YRC Freight provides transportation and global logistics services. He was president of Yellow Transportation, Inc., from September 1996 through November 1999. Prior to that, Mr. Zollars was senior vice president of Ryder Integrated Logistics. He also held various executive positions with Eastman Kodak and serves on the board of directors of Prologis, Inc.   Mr. Zollars has a bachelor's in economics from the University of Minnesota and is a member of Phi Beta Kappa.

    Cerner's Board of Directors retained Heidrick & Struggles, a leading global executive search firm, to assist in its search process.

    About Cerner

    Cerner's health technologies connect people and information systems in thousands of worldwide facilities dedicated to creating smarter and better care for individuals and communities. Recognized globally for innovation, Cerner assists clinicians in making care decisions and assists organizations in managing the health of their populations. The company also offers an integrated clinical and financial system to help manage day-to-day revenue functions, as well as a wide range of services to support clinical, financial and operational needs, focused on people. For more information, visit Cerner.com, The Cerner Blog, The Cerner Podcast or connect on Facebook, Instagram, LinkedIn or Twitter. Nasdaq: CERN. Smarter Care. Better Outcomes. Healthier You.

    Investor Contact: Allan Kells, (816) 201-2445, [email protected]

    Media Contact: Misti Preston, (816) 299-2037, [email protected]

    Cerner's Internet Home Page: www.cerner.com

    All statements in this press release that do not directly and exclusively relate to historical facts constitute forward-looking statements. These forward-looking statements are based on the current beliefs, expectations and assumptions of Cerner's management with respect to future events and are subject to a number of significant risks and uncertainties. It is important to note that Cerner's performance, and actual results, financial condition or business could differ materially from those expressed in such forward-looking statements. The words "believe", "opportunities" and "positioned" are intended to identify such forward-looking statements. For example, our forward-looking statements include statements regarding Cerner's future growth or success. Factors that could cause or contribute to such differences include, but are not limited to, the risks associated with the loss or recruitment and retention of key personnel or the failure to successfully develop and execute succession planning to assure transitions of key associates and their knowledge, relationships and expertise. Additional discussion of these and other risks, uncertainties and factors affecting Cerner's business is contained in Cerner's filings with the Securities and Exchange Commission. The reader should not place undue reliance on forward-looking statements, since the statements speak only as of the date that they are made. Except as required by law, Cerner undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events, or changes in our business, results of operations or financial condition over time.



    Primary Logo

    Get the next $CERN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CERN

    DatePrice TargetRatingAnalyst
    4/11/2022Buy → Hold
    Argus
    12/22/2021Overweight → Sector Weight
    Keybanc
    12/21/2021$85.00 → $95.00Equal-Weight
    Morgan Stanley
    12/21/2021$86.00 → $95.00Outperform → Sector Perform
    RBC Capital
    12/21/2021$88.00 → $95.00Outperform → Market Perform
    SVB Leerink
    12/20/2021$77.00 → $85.00Underweight → Equal-Weight
    Morgan Stanley
    11/17/2021$82.00Neutral
    Robert W. Baird
    11/17/2021$82.00Neutral
    Baird
    More analyst ratings

    $CERN
    Leadership Updates

    Live Leadership Updates

    See more
    • MultiPlan Announces CFO Transition

      MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, announced today its CFO transition plan and named Doug Garis as EVP and CFO, effective August 5, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731993142/en/Doug Garis named EVP and CFO of MultiPlan (Photo: Business Wire) Jim Head, who has served as EVP and CFO of MultiPlan since November 2021, will transition to a Strategic Advisor role to the Company through the end of the

      8/1/24 6:00:00 AM ET
      $DOOR
      $MPLN
      $ORCL
      $CERN
      Forest Products
      Basic Materials
      Business Services
      Consumer Discretionary
    • Thomas H. Lee Partners Appoints Paul Black As a Consultant for Healthcare Group

      Healthcare IT Industry Expert Will Support the Firm's HCIT Strategy Thomas H. Lee Partners, L.P. ("THL"), a premier private equity firm investing in middle-market growth companies, today announced the appointment of Paul Black as a consultant for the firm's healthcare investment group. Black, who brings more than 25 years of experience leading companies in healthcare information technology ("Healthcare IT"), will support the team's efforts in identifying, sourcing, and growing investment opportunities across the healthcare market. "We are very pleased to welcome Paul to THL as a consultant for the firm's healthcare group," said Shahab Vagefi, Managing Director at THL. "THL has had a longs

      10/11/22 9:00:00 AM ET
      $CERN
      $HQY
      $MDRX
      Managed Health Care
      Health Care
      Business Services
      Consumer Discretionary
    • COMPREHENSIVE HEALTHCARE SYSTEMS ANNOUNCES APPOINTMENT OF NEW BOARD MEMBER AND CHIEF EXECUTIVE OFFICER

      CALGARY, AB, Jan. 25, 2022 /CNW/ - Comprehensive Healthcare Systems Inc. (TSXV:CHS) (the "Company" or "CHS"), an industry leader in Healthcare Benefits Administration software and services, is pleased to announce the appointment of Chris Cosgrove as the Company's new President and Chief Executive Officer ("CEO") and to its board of directors effective February 1, 2022.  Mr. Cosgrove has 25 years of management and leadership experience in the healthcare technology industry and will replace CHS founder, Dr. Hassan Mohaideen, who will continue in his role as Chairman of the board of directors (the "Board") and be appointed Chief Medical Officer of the Company. "With a proven track record of lea

      1/25/22 8:00:00 AM ET
      $CERN
      $GE
      $MCK
      Managed Health Care
      Health Care
      Consumer Electronics/Appliances
      Technology

    $CERN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • MultiPlan Announces CFO Transition

      MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, announced today its CFO transition plan and named Doug Garis as EVP and CFO, effective August 5, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731993142/en/Doug Garis named EVP and CFO of MultiPlan (Photo: Business Wire) Jim Head, who has served as EVP and CFO of MultiPlan since November 2021, will transition to a Strategic Advisor role to the Company through the end of the

      8/1/24 6:00:00 AM ET
      $DOOR
      $MPLN
      $ORCL
      $CERN
      Forest Products
      Basic Materials
      Business Services
      Consumer Discretionary
    • Thomas H. Lee Partners Appoints Paul Black As a Consultant for Healthcare Group

      Healthcare IT Industry Expert Will Support the Firm's HCIT Strategy Thomas H. Lee Partners, L.P. ("THL"), a premier private equity firm investing in middle-market growth companies, today announced the appointment of Paul Black as a consultant for the firm's healthcare investment group. Black, who brings more than 25 years of experience leading companies in healthcare information technology ("Healthcare IT"), will support the team's efforts in identifying, sourcing, and growing investment opportunities across the healthcare market. "We are very pleased to welcome Paul to THL as a consultant for the firm's healthcare group," said Shahab Vagefi, Managing Director at THL. "THL has had a longs

      10/11/22 9:00:00 AM ET
      $CERN
      $HQY
      $MDRX
      Managed Health Care
      Health Care
      Business Services
      Consumer Discretionary
    • Oracle Completes Acquisition of Cerner

      AUSTIN, Texas, June 7, 2022 /PRNewswire/ -- Oracle Corporation (NYSE:ORCL) announced that a majority of the outstanding shares (the "Shares") of Cerner Corporation (NASDAQ:CERN) were validly tendered, and the other conditions to the tender offer have been satisfied or waived.  The deal will close on June 8, 2022. American Stock Transfer & Trust Company LLC, the depositary for the tender offer, has indicated that as of 12:00 midnight, Eastern time, at the end of the day on June 6, 2022, approximately 204,280,589 Shares, or 69.2% of the total Shares, have been validly tendered.

      6/7/22 8:00:00 AM ET
      $CERN
      $ORCL
      Managed Health Care
      Health Care
      Computer Software: Prepackaged Software
      Technology

    $CERN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Cerner Corporation (Amendment)

      SC 13G/A - CERNER Corp (0000804753) (Subject)

      2/9/22 3:33:35 PM ET
      $CERN
      Managed Health Care
      Health Care
    • SEC Form SC 13G/A filed

      SC 13G/A - CERNER Corp (0000804753) (Subject)

      2/10/21 10:46:44 AM ET
      $CERN
      Managed Health Care
      Health Care

    $CERN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Cerner downgraded by Argus

      Argus downgraded Cerner from Buy to Hold

      4/11/22 8:49:43 AM ET
      $CERN
      Managed Health Care
      Health Care
    • Cerner downgraded by Keybanc

      Keybanc downgraded Cerner from Overweight to Sector Weight

      12/22/21 4:29:54 AM ET
      $CERN
      Managed Health Care
      Health Care
    • Morgan Stanley reiterated coverage on Cerner with a new price target

      Morgan Stanley reiterated coverage of Cerner with a rating of Equal-Weight and set a new price target of $95.00 from $85.00 previously

      12/21/21 7:53:30 AM ET
      $CERN
      Managed Health Care
      Health Care

    $CERN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Wise R Halsey returned $302,860 worth of shares to the company (3,188 units at $95.00) to cover withholding tax

      4 - CERNER Corp (0000804753) (Issuer)

      6/9/22 5:31:43 PM ET
      $CERN
      Managed Health Care
      Health Care
    • SEC Form 4: Zollars William D returned $349,600 worth of shares to the company (3,680 units at $95.00), closing all direct ownership in the company (tax withholding)

      4 - CERNER Corp (0000804753) (Issuer)

      6/9/22 5:27:48 PM ET
      $CERN
      Managed Health Care
      Health Care
    • SEC Form 4: Riedel George Andrew closing all direct ownership in the company (withholding tax)

      4 - CERNER Corp (0000804753) (Issuer)

      6/9/22 5:27:18 PM ET
      $CERN
      Managed Health Care
      Health Care

    $CERN
    Financials

    Live finance-specific insights

    See more

    $CERN
    SEC Filings

    See more
    • CERNER ANNOUNCES QUARTERLY DIVIDEND

      KANSAS CITY, Mo., March 15, 2022 /PRNewswire/ -- Cerner Corporation (NASDAQ:CERN), a global healthcare technology company, today announced that its Board of Directors (the "Board") declared a cash dividend to stockholders of $0.27 per issued and outstanding share. The cash dividend will be payable April 19, 2022, to shareholders of record as of the close of business March 28, 2022. Cerner intends to pay regular quarterly cash dividends, with future declarations subject to Board approval and their determination that the declaration of dividends remains in the best interests of

      3/15/22 9:00:00 AM ET
      $CERN
      Managed Health Care
      Health Care
    • Cerner Announces Increased Quarterly Dividend

      KANSAS CITY, Mo., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (NASDAQ:CERN), a global healthcare technology company, today announced that its board of directors declared a cash dividend to stockholders of $0.27 per issued and outstanding share, up 23 percent from the prior quarterly dividend of $0.22. The cash dividend will be payable January 11, 2022, to shareholders of record as of the close of business December 27, 2021. Cerner intends to pay regular quarterly cash dividends, with future declarations subject to Board approval and their determination that the declaration of dividends remains in the best interests of Cerner and its shareholders. The decision of whether to pay fu

      12/10/21 9:00:00 AM ET
      $CERN
      Managed Health Care
      Health Care
    • Cerner Reports Third Quarter 2021 Results

      Delivers Strong Results Across Key MetricsGAAP Operating Margin and Diluted EPS Lower; Adjusted Operating Margin and Adjusted Diluted EPS Both up Sharply vs. Year-Ago QuarterFull-Year Guidance Increased KANSAS CITY, Mo., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (NASDAQ:CERN) today announced results for the 2021 third quarter that ended September 30, 2021. The third quarter 2021 earnings release can be viewed here as well as on the company's website at https://investors.cerner.com/financial-releases. Cerner will host an earnings conference call to provide additional detail on the Company's results and outlook at 8:00 a.m. CT on October 29, 2021. On the call, Cerner will disc

      10/29/21 7:30:00 AM ET
      $CERN
      Managed Health Care
      Health Care
    • SEC Form 15-12G filed by Cerner Corporation

      15-12G - CERNER Corp (0000804753) (Filer)

      6/23/22 1:25:00 PM ET
      $CERN
      Managed Health Care
      Health Care
    • SEC Form S-8 POS filed by Cerner Corporation

      S-8 POS - CERNER Corp (0000804753) (Filer)

      6/8/22 9:17:02 AM ET
      $CERN
      Managed Health Care
      Health Care
    • SEC Form S-8 POS filed by Cerner Corporation

      S-8 POS - CERNER Corp (0000804753) (Filer)

      6/8/22 9:15:28 AM ET
      $CERN
      Managed Health Care
      Health Care